StockData
Moderna, Inc. logo

Moderna, Inc.

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30567% above fair value
$220.83−0.89 (-0.40%)

Close on Nov 2, 2026Market cap $88.16BP/E –Yield –

Moderna ClinicalTrials.gov registry by Quarter

ClinicalTrials.gov registry — Cumulative Moderna-sponsored studies (studies)

QuarterlyAnnual

Moderna ClinicalTrials.gov registry: 139.00 studies in Q2 2026, up 9.4% from a year earlier. That is the highest of the 34 quarters on record here.

Latest, Q2 2026
139.00
Period ended Jun 30, 2026
Change on a year earlier
+9.4%
127.00 in Q2 2025
History
34 quarters
Since Q1 2018
Sources
1
ClinicalTrials.gov API v2 (ModernaTX, Inc.)

Where the Q2 2026 figure comes from

Source: ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗

Reported in ClinicalTrials.gov API v2 (ModernaTX, Inc.).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedClinicalTrials.gov registry — Cumulative Moderna-sponsored studies (studies)Year on yearSource
Q2 2026Jun 30, 2026139.00+9.4%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2026Mar 31, 2026137.00+9.6%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2025Dec 31, 2025135.00+10.7%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2025Sep 30, 2025131.00+12.0%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q2 2025Jun 30, 2025127.00+12.4%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2025Mar 31, 2025125.00+13.6%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2024Dec 31, 2024122.00+16.2%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2024Sep 30, 2024117.00+17.0%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q2 2024Jun 30, 2024113.00+24.2%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2024Mar 31, 2024110.00+31.0%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2023Dec 31, 2023105.00+40.0%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2023Sep 30, 2023100.00+47.1%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q2 2023Jun 30, 202391.00+46.8%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2023Mar 31, 202384.00+64.7%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2022Dec 31, 202275.00+56.3%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2022Sep 30, 202268.00+70.0%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗

Breakdown

What makes up clinicalTrials.gov registry

Cite this data

StockData. (2026). Moderna ClinicalTrials.gov registry, quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/ctgov-cum-all-studies

See every metric in the Moderna KPI table. Data updated Nov 3, 2026.